earnings
confidence high
sentiment negative
materiality 0.70
Cross Country Healthcare Q2 revenue down 19% YoY, net loss of $6.7M, negative adjusted EPS
CROSS COUNTRY HEALTHCARE INC
2025-Q2 EPS reported
-$0.22
revenue$567,480,000
- Revenue $274.1M, down 19% YoY; gross margin 20.4%, down 40 bps.
- Net loss attributable to common stockholders $6.7M ($0.20 diluted EPS loss); vs Q2 2024 EPS of $0.27 income.
- Adjusted EBITDA $7.6M (2.8% margin), down 46% YoY.
- Adjusted EPS loss of $0.01, improved from $0.11 loss in Q2 2024.
- Cash from operations $4.2M, down 95% YoY.